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Abstract
Background: This study aims to evaluate the efficacy of limb salvage with primary tumor resection on patients
with solitary bone metastasis.
Methods: A retrospective treatment outcome review was performed on 20 patients with solitary bone metastasis
as the primary clinical symptom who were admitted to the hospital between 2006 and 2010. With primary tumor
resection, 18/20 patients received limb salvage surgery simultaneously. Pain scoring was assessed using the 0 to 10
numerical rating scale. The quality of life scoring was performed before and 3 months after surgery using the SF-30
scoring system. In addition, limb function was assessed 3 months after the operation using the Scoring System of
American Musculoskeletal Tumor Society system (MSTS).
Results: The pain symptom was significantly ameliorated after the operation (t = 26.653, P < 0.001), and the quality
of life dramatically improved (t = −20.581, P < 0.001). The postoperative MSTS scores ranged from 18 to 27. The
average score was 23.10 ± 2.36. The Kaplan-Meier analysis showed that no significant differences (χ2 = 1.589,
P = 0.207) were observed in the tumor-free survival time between the wide and marginal resections.
Conclusions: The application of the wide or marginal excision for the primary lesion and bony metastasis
focus, based on the principles of primary bone tumors, can significantly relieve the pain and improve the
quality of life and limb function of patients whose solitary bone metastasis was manifested as the first sign.
Keywords: Solitary bone metastasis, Limb salvage, Limb function, Life quality, Regional recurrence
Background
In metastatic cancer, the bone is one of the most likely
metastatic sites just following the lung and the liver.
Bone metastases often occur in some cancers, including
breast cancer, prostate cancer, kidney cancer, thyroid
cancer, and lung cancer, of which breast cancer and
prostate cancer take the lead [1]. Seventy percent of
bone metastases occur in the axial skeleton, while 10 %
in the limbs. Limb bone metastases occur in the prox-
imal long bones, such as the proximal humerus and the
proximal femur [2]. Patients with bone metastases often
experience severe complications, including pain, limited
mobility, hypercalcemia, pathologic fracture, spinal cord
compression, or nerve root compression, which will ser-
iously affect the patient’s quality of life, thereby affecting
the treatment of the primary tumor [3]. In cancer pa-
tients, emergence of bone metastases usually implies
that the diseases are in the middle or final term. There-
fore, improving the quality of life, alleviating local symp-
toms, and curing relative complications are the primary
purposes for bone metastases.
As reported in the previous literature, the general sur-
gical treatment of limb bone metastases was amputation
[4]. But now, the most well accepted therapy is the pal-
liative surgical treatment or the limb salvage surgery in-
cluding chemotherapy, radiotherapy, bisphosphonate,
and analgesic drug therapy [5]. For bone metastases in
limbs, palliative surgery mainly aims to treat or lower
the risk of the pathologic fracture of the long bone and
the hip. The primary surgical approaches include plate
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fixation, large segment resection and reconstruction,
intramedullary nails, and external fixation. Hardman
et al. reported that taking the preventive internal fixation
treatment for limb bone metastases has more favorable
effort in prolonging survival and improving the quality
of life than that after pathological fracture [6]. Studies
have shown that patients with solitary bone metastasis
have a better prognosis than those with multiple ones
[7]. Therefore, for patients whose solitary bone metasta-
sis was manifested as the first sign, wide or marginal ex-
cision for the primary lesion and bony metastasis focus
according to treatment principles of the primary bone
tumor can improve the patients’ quality of life. This
group of patients received limb salvage surgery with
primary tumor resection simultaneously. To analyze the
efficacy of this strategy, the pain, quality of life, limb




From October 2006 to August 2010, 20 patients whose
solitary bone metastasis was manifested as the first sign
were treated in our hospital. The basic information of
the 20 patients was shown in Table 1. The more detailed
information of the patients was shown in Additional file 1:
Table S1. There were 9 men and 11 women. The average
age was 58.7 years (ranged 43–70 years). The follow-up
time ranged from 6 to 30 months; the mean time is
14.5 months. The metastatic sites are located in the femur
(n = 11), humerus (n = 7), and tibia (n = 2). The primary
cancers involved lung cancer (n = 8), breast cancer (n = 3),
kidney cancer (n = 4), prostate cancer (n = 2), thyroid
cancer (n = 1), cervical cancer (n = 1), and gastric cancer
(n = 1). The complaints included simple pain in 11 pa-
tients, pain and bump in 2, and pathological fracture in 6
patients. All the patients were admitted to hospital for
pain at the site of bone metastases, local mass, or patho-
logic fractures as the first clinical manifestation, and
further examination revealed the primary tumor. Primary
tumor and bone metastases were confirmed by patho-
logical examination. Written informed consent was ob-
tained from the patients, and the study was performed in
accordance with the Declaration of Helsinki and approved
by the ethics committee of the Sixth People’ hospital of
Shanghai Jiao Tong University.
Surgical procedures
Solitary bone metastasis was manifested as the first sign
in all the patients in our group. Preoperative closed bi-
opsy of bone lesion confirmed it was metastasis. In com-
bination with other organ lesions, the patients were
diagnosed as primary tumor associated with solitary bone
metastases in the limbs. Eighteen patients underwent limb
salvage surgery together with the primary tumor resection
simultaneously according to the treatment principle of
primary bone tumor under same anesthesia. Of two cases
of prostate cancer, the patients were admitted to hospital
because of pathological fracture of the proximal femur.
The patient received proximal femoral tumor resection
and prosthetic replacement, and the endocrine therapy
was carried out after surgery. The other patient received
bone tumor resection and prosthetic replacement, accom-
panying with the castration therapy. According to the
Enneking Staging System, wide resection was done in 11
patients and marginal resection in 9 patients. The diagno-
sis was confirmed by pathological examination postopera-
tively. Perioperative complications were treated. The
patients underwent adjuvant systemic chemotherapy or
(and) local radiotherapy.
Follow-up
Pain scoring and quality of life scoring were carried out
preoperatively and postoperatively. Pain assessment was
conducted using the 0 to 10 numerical rating scale pre-
operatively and 1 month after surgery. The quality of life
scoring was performed preoperatively and 3 months
after surgery using the SF-36 scoring system [8]. All rat-
ings were done by the same person. Limb function score
was evaluated using Musculoskeletal Tumor Society
scoring system (MSTS score) 3 months after surgery [9].
Statistical evaluation
The data were compiled and analyzed using SPSS version
21.0. Continuous data were expressed as mean values and
standard deviation. Comparisons between different time
points were done using paired Student’s t test. The
Kaplan-Meier analysis was employed for survival analysis
between groups. Tumor-free survival time is the period
from surgery to the presence of new lesions. A significant
result was taken as p < 0.05.
Results
Surgical complications
The average follow-up period was 14.5 months (ranged
from 6 to 30 months). No patient was default in follow-
up. Superficial incision infection was found in one patient,
who was cured after debridement. Deep vein thrombosis
was found in one patient and resolved after systemic
anticoagulation therapy for 1 week. Pulmonary infection
was detected in one patient who was treated by antibiotic
therapy.
Result of evaluation
As shown in Table 2, the mean preoperative pain score
was 8.10 ± 1.17, whereas the postoperative pain score
was 1.55 ± 0.69. The symptom was significantly amelio-
rated after the operation (t = 26.653, P < 0.001). The
Cheng et al. World Journal of Surgical Oncology  (2016) 14:31 Page 2 of 6
Table 1 Basic information of the 20 patients












1 Male 43 Proximal femur Lung cancer Marginal 8 1 25 34 72 13 9
2 Male 56 Proximal femur Prostate cancer Wide 10 2 24 28 61 18 18
3 Female 46 Proximal humerus Lung cancer Wide 7 1 23 45 82 16 13
4 Female 45 Proximal humerus Kidney cancer Wide 9 2 22 32 65 30 30
5 Female 55 Middle humerus Lung cancer Wide 7 1 24 34 69 12 12
6 Male 68 Proximal femur Lung cancer Marginal 8 1 19 23 51 9 7
7 Female 67 Proximal femur Cervical cancer Wide 10 1 23 28 63 11 9
8 Female 55 Middle humerus Lung cancer Wide 6 1 27 37 72 6 5
9 Female 65 Proximal humerus Breast cancer Marginal 8 2 26 38 65 10 10
10 Female 55 Proximal humerus Thyroid cancer Wide 7 1 22 68 82 19 19
11 Female 58 Proximal tibia Breast cancer Marginal 9 1 25 30 63 14 14
12 Male 64 Distal femur Kidney cancer Marginal 8 3 24 33 60 16 12
13 Male 69 Proximal femur Prostate cancer Wide 8 1 23 41 67 14 11
14 Male 67 Proximal femur Lung cancer Wide 9 3 20 21 43 7 4
15 Male 58 Proximal tibia Kidney cancer Marginal 7 2 18 25 57 17 12
16 Female 45 Proximal humerus Lung cancer Marginal 10 2 23 34 68 14 9
17 Female 70 Proximal femur Breast cancer Wide 8 2 21 39 58 25 21
18 Male 66 Proximal femur Gastric cancer Marginal 7 1 25 45 68 17 17
19 Male 63 Proximal femur Kidney cancer Marginal 7 1 26 42 68 13 11
20 Female 59 Distal femur Lung cancer Wide 9 2 22 41 70 9 9














mean preoperative quality of life score was 35.90 ±
10.26, whereas the mean postoperative score was
65.20 ± 9.14. Therefore, the quality of life dramatically
improved (t = −20.581, P < 0.001). The postoperative
MSTS scores ranged from 18 to 27. The average
score was 23.10 ± 2.36. All patients recovered the abil-
ity of daily living and could within walk with or with-
out the aid of walker 1 month after surgery.
Tumor-free survival time
In our group, 11 patients received wide resection and
9 patients received marginal resection. As shown in
Fig. 1, the Kaplan-Meier analysis revealed that there
was no significant difference between wide resection
and marginal resection in tumor-free survival time
(χ2 = 1.589, P = 0.207).
Discussion
Metastatic bone cancer is a common malignancy. Most
malignant tumors involve in bone metastases, 80 % of
breast, prostate, and lung cancer are in the process [10].
In our study, the primary cancers involved lung cancer
(n = 8), breast cancer (n = 3), kidney cancer (n = 4), pros-
tate cancer (n = 2), thyroid cancer (n = 1), cervical cancer
(n = 1), and gastric cancer (n = 1). Nowadays, the
treatment of bone metastases is a comprehensive ther-
apy. Although radiation therapy play a role in pain con-
trol and prevention of pathological fractures, surgery is
more effective in functional recovery and prevention of
the progression of local tumor [11]. Moreover, patients
with bone metastases are usually older; they can hardly
withstand the long-term and highly toxic chemotherapy.
Thus, moderate surgery has a positive significance for
patients with bone metastases. Surgical approaches vary
in different patients. Factors affecting the surgical
methods include age, systemic condition, and extent of
bone metastases, the existence of metastases outside the
bone, as well as the patient’s wishes [12].
Bone metastases are the most common first manifest-
ation of lung cancer, kidney cancer, myeloma, and
lymphoma. Although breast and prostate cancer are the
most common primary sites of bone metastases, they
rarely take bone metastases as the first manifestation
[13]. However, in our group, bone metastases were rec-
ognized as the first manifestation in all patients, and fur-
ther examination revealed the primary tumor. For
metastatic cancer patients without pathological fracture,
it is advisable to receive non-surgical treatment. While
for most patients with pathological fracture, limb salvage
surgery is a preferable choice [14]. Pathological fracture
occurs mainly in the proximal end of the bone and the
backbone (Fig. 2). Therefore, the surgical fixation methods
vary according to the metastatic tumor site. For fracture
adjacent to the joint, tumor resection, and prosthetic re-
placement are mainly used. Six patients with pathological
fracture adjacent to the joint underwent tumor resection
Fig. 1 The comparison of tumor-free survival time between wide resection and marginal resection
Table 2 Pre- and postoperative pain and quality of life scores
Preoperative Postoperative t p
Pain score 8.10 ± 1.17 1.55 ± 0.69 26.653 <0.001
Quality of life score 35.90 ± 10.26 65.20 ± 9.14 −20.581 <0.001
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and prosthetic replacement. When the fracture locates in
the backbone, bone cement filling with intramedullary
nailing is the better choice [15]. For bone metastases, pa-
tients without pathological fracture, Mirels et al. consid-
ered that if a total Mirels score of 8 or greater was
identified, it was advisable to take measures to prevent the
occurrence of pathologic fractures. If the Mirels score was
greater than 9, the risk of pathological fractures rises to
33 %, it is necessary to take preventive internal fixation
[16]. Studies have shown that, in the lung cancer, patients
with bone metastases, limb salvage surgery with primary
tumor resection simultaneously could significantly im-
prove their survival time and prognosis (Fig. 3) [17, 18]. In
the 20 patients of this group, bone metastases were recog-
nized as the first performance of clinical manifestations,
and further examination revealed the primary lesion.
Among them, 18 received salvage treatment, consisting of
tumor resection and prosthetic replacement, simultan-
eously with the resection of the primary tumor. For pros-
tate cancer patients, one patient received endocrine
therapy after limb salvage surgery; the other was given
castration therapy. Pain was alleviated, and the quality of
life was improved significantly after surgery.
In this group, 11 patients received wide resection of
metastatic tumor, while 9 patients received marginal re-
section together with postoperative radiotherapy as an
adjuvant therapy, which also received good control of
the local tumor. No local recurrence was observed in
this group. And there was no significant difference be-
tween the patients with wide resection and those with
Fig. 2 Typical case 1. a X-ray revealed bone destruction at the proximal end of the left femur; b MRI demonstrated hypointense signal in T1-
weighted images; c CT revealed right lung cancer; d postoperative gross observation; e postoperative X-ray
Fig. 3 Typical case 2. a X-ray revealed bone destruction at the proximal end of the left humerus; b MRI demonstrated hypointense signal in T1-
weighted images; c CT revealed right lung cancer; d postoperative gross observation; e postoperative X-ray
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marginal resection in their tumor-free survival time.
Bauer reported that in Karolinska hospital, nine kidney
cancer patients with solitary bone metastases underwent
wide or marginal resection with no local recurrence or
implant failures during follow-up [13]. Similarly, as re-
ported in literature, the presence of primary cancer and
poor performance status were identified as independent
prognostic factors using Cox regression multivariate
analysis; however, surgical margin was not significantly
related to patient survival [19]. Cho also showed that
wide resection conveyed no survival advantage over cur-
ettage in patients with solitary bone metastasis from he-
patocellular carcinoma [20]. Therefore, wide or marginal
tumor resection is not the major factor in determining
the tumor-free survival time.
Conclusions
In short, for the bone metastases, patients whose solitary
bone metastasis was manifested as the first sign, limb
salvage surgery with primary tumor resection simultan-
eously according to the treatment principles of primary
bone cancer can reduce the patients’ pain and improve
their quality of life, without increasing the rate of local
recurrence. However, as the patients were followed up in
a relative short time, the impact of limb salvage therapy
on patients’ overall survival needs further follow-up.
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